We're looking for a Senior Trial Manager to join our team. Find out more about the role and how to apply here: jobs.icr.ac.uk/vacancies/13... #ResearchJobs #ClinicalTrials 🧪

We are currently looking for a new Trial Statistician/Senior Trial Statistician to join our team. You can find more details, including how to apply, here: jobs.icr.ac.uk/vacancies/13... 🧪 #ResearchJobs

Our Sustainability Project Manager, Jessica Griffiths, attended the Conference on Research Outcomes in Environmental Sustainability jointly run by the Medical Research Council @nihr.bsky.social, and Greener NHS yesterday to present our poster on Greener Trials. #GreenSky 🧪

If you are @myesmo.bsky.social Congress this weekend, don't miss Prof @christinayap.bsky.social's presentation on Common mistakes in biostatistics: a crash course, in the Young Oncologists session tomorrow.

Our Assistant Operations Director, Dr @lisa-fox.bsky.social, is presenting the Greener Trials project at next week's @bigxresearch.bsky.social Pink October Webinar 2025. Find out more and register to attend here: bigagainstbreastcancer.org/events/big-p... #BreastCancer #GreenSky

Join our team! We are recruiting an Application Developer for our Greener Trials project. The successful applicant will develop an online Greener Trials Toolkit to help researchers assess and mitigate the environmental impact of their trials. #Greensky #ITjobs 🧪 jobs.icr.ac.uk/vacancies/13...

I’ve been speaking with yr11-13s about careers in cancer research this evening. These events always remind me of how lucky I am to work in a multidisciplinary research setting - applying statistics to things that matter to patients. @icr-ctsu.bsky.social @icr.ac.uk

Earlier this week some of our staff attended the UK CRC Trial Management Operational Meeting where they shared some recent experiences.

We were at the NIHR Biomedical Research Centre and Clinical Research Facility Research inclusion conference earlier this week, where Dr Yemi Akala presented our INTERACT Project.

Results from the TORPEdO trial were presented at the American Society of Radiation Oncology (ASTRO) Annual Meeting last week.

We are excited to be attending the 67th annual #ASTRO meeting in San Francisco where the TORPEdO primary results and the two-year toxicity outcomes from PACE-C will be presented. 🧪

Today is #WorldCancerResearchDay 🌎 👩‍🔬 👨‍🔬 We're incredibly proud to have a community that is driving innovation, making ground-breaking discoveries, and transforming the future of cancer research. Thank you to everyone who is helping us move closer to defeating cancer.

We're currently looking for a Trials Methodologist/Senior Trials Methodologist to join our team. You can find out more about the role and how to apply here: jobs.icr.ac.uk/vacancies/13... #ResearchJobs #TrialsMethodology🧪

New paper: we surveyed people in the UK who have experienced breast cancer, investigating the hidden costs and their support needs. www.nature.com/articles/s44... 🧪

Recruitment to cancer #ClinicalTrials is often highly selective, and some people face barriers to participation. To prevent these issues from limiting our progress against the disease, we're working to bridge the gap between clinical trials and real-world practice ⬇️ www.icr.ac.uk/research-and...

We're at the @abcuk.bsky.social bladder cancer training event today, to share information about our new trial COBRA.

Thank you to all the participants in FAST-Forward Boost which recruited its 100th patient last week. The trial is investigating whether #Radiotherapy to treat #BreastCancer can be given in fewer treatment visits. You can learn more about the trial here: www.icr.ac.uk/ff-boost

Congratulations to @christinayap.bsky.social for being awarded a Cross-Sector Experience Award from @acmedsci.bsky.social to support her work on early phase and adaptive trials methodology, and the integration of patient-reported outcomes.

We are looking for a new Principal Statistician to join our team. If you're interested in this role or know someone who might be, please see the link below for more details. #ResearchJobs #Statistician 🧪 jobs.icr.ac.uk/vacancies/12...

We are looking for a new Trial Manager to join our team. If you're interested in this role or know someone who might be, please see the link below for more details. #ResearchJobs 🧪 jobs.icr.ac.uk/vacancies/12...

We were joined this afternoon by MPs @luketaylorld.bsky.social, @bobbywdean.bsky.social and @paulkohlersw19.bsky.social 👋 Luke, Bobby and Paul met with Dr @maggiecheang.bsky.social to discuss her role at the ICR and the impact of her interdisciplinary research in the @icr-ctsu.bsky.social

On Friday, PhD student Emily Alger @mle-alger.bsky.social will present her work “International consensus-driven recommendations for patient-reported outcome research objectives in early phase dose-finding oncology clinical trials: OPTIMISE-ROR” at the ESMO TAT Asia Congress. 🧪

We are looking for a new Data Manager to join our team. If you're interested in this role or know someone who might be, please see the link below for more details. #ResearchJobs 🧪 jobs.icr.ac.uk/vacancies/12...

We've just published a paper describing our work with patient and public advisors on our SPRUCE study. @morgainestiles.bsky.social researchinvolvement.biomedcentral.com/articles/10....

Published today in @natmed.nature.com www.nature.com/articles/s41... combination of avutometinib and defactinib in LGSOC. @icr.ac.uk‬ @icrdduiit.bsky.social‬ @icr-ctsu.bsky.social @royalmarsden.org @ecmc-uk.bsky.social @nihr.bsky.social‬ ‪@crukconvergence.bsky.social @cancerresearchuk.org ‪

Results of the PERSEUS1 trial were published in European Urology Oncology this week: www.sciencedirect.com/science/arti...

PACE-C 12-week acute toxicity results were published online in @thelancetoncol.bsky.social last week. 🧪 You can read the paper here: www.sciencedirect.com/science/arti...

I am grateful to my mentors and the support from @icr.ac.uk @cancerresearchuk.org and @breastcancernow.bsky.social for my research ! and my team and colleagues @icr-ctsu.bsky.social

Our statistician, Monisha Dewan, will be giving a rapid fire talk and presenting a poster on ‘Predicting risk of recurrence using a multiparametric algorithm for women ≥70 years old with early ER+HER2- tumours in the POETIC trial’ at the @nihr.bsky.social statistics conference tomorrow. 🧪

The primary results of the HERMES #ClinicalTrial have been published in the Red Journal. HERMES investigated whether patients with localised #ProstateCancer are best treated with 2 fractions of #SBRT over 8 days or 5 fractions over 10 days. www.sciencedirect.com/science/arti...

Congratulations to PhD student, Emily Alger @mle-alger.bsky.social, who received the American Statistical Association Biopharmaceutical Scholarship Award in May, recognizing her notable achievements, research, leadership, volunteering and project work in the area of biopharmaceutical statistics. 🧪

New publication: Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes - The Lancet Oncology 🧪https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2825%2900194-9/fulltext

Do contact me if you are interested in this leadership role - I am keen to hear from you if you want to help shape our cancer clinical trials research.

Are you an experienced #Biostatistician looking for the next step in your #ClinicalTrials career? We are recruiting for a research group leader to develop and grow our academic clinical trials portfolio. Find out more and apply here: #StatsJobs #ResearchJobs 🧪 jobs.icr.ac.uk/vacancies/12...

We are currently looking for Translational Sample Coordinator to collate sample and imaging collections from ICR’s radiotherapy trials portfolio and facilitate access for researchers. Further details can be found here: jobs.icr.ac.uk/vacancies/12... #ScienceJobs #ResearchJobs 🧪

Yesterday we celebrated World Environment Day, so we wanted to share some of the things ICR-CTSU has done to reduce waste and improve our environmental impact. Read about our activities below 👇

A fantastic to mark World Environment Day, and a brilliant first meeting! I'm excited about the work we will do together @icr-ctsu.bsky.social @icr.ac.uk @tmrp.bsky.social @wellcometrust.bsky.social @universityofliverpool @universityofaberdeen

One of our PhD students @mle-alger.bsky.social gave a talk ‪@pintofscience.uk‬ last year, explaining Bayesian statistics in the context of everyday life - worth a watch particularly if you're a non-specialist interested in this stats methodology 🧪: www.youtube.com/watch?v=-471...

On #ClinicalTrialsDay we would like to thank all those involved in our trials. Each year hundreds of people join our research at NHS hospitals and worldwide. Without participants and colleagues supporting our trials we wouldn't be able to work to transform cancer care for future patients.

This #internationalclinicaltrialsday it's fantastic to be posting about #GreenerTrials. It was a pleasure to work with the team on this animation. Watch to see how to make trials greener, without compromising health outcomes. @icr-ctsu.bsky.social @icr.ac.uk @tmrp.bsky.social @hrb-tmrn.bsky.social

Several of our students and staff are heading to the Society for Clinical Trials conference next week to present their work. See below for details of their presentations 👇

BREAKING: A new combination of two drugs for ovarian cancer has been approved by the FDA. Two trials led by researchers at the ICR & The Royal Marsden were key to the FDA approval of the world’s first targeted therapy for a specific type of low grade serous ovarian cancer. Read more: rb.gy/zo1hyy

We are looking for a new Quality Assurance Manager. The post holder will plan, coordinate and conduct audits, be responsible for ensuring procedures are fit for purpose, and provide advice and support to colleagues. #ScienceJobs #ClinicalTrials 🧪 Find out more here: jobs.icr.ac.uk/vacancies/12...

At #ESTRO2025, an abstract based on the PACE-B study scored in the top 5% of submitted abstracts. This abstract explored predictive factors for late urinary toxicity after prostate SBRT and identified several predictive factors which may help to inform treatment selection in future.

Congratulations to Professor Judith Bliss, Professor Murray Brunt, and the ICR Clinical Trials and Statistics Unit @icr-ctsu.bsky.social, who have been honoured with the award for Best Clinical Paper presented at the European Society for Radiotherapy and Oncology (ESTRO) 2025 conference. 👏

We are currently recruiting for 3 roles: Data manager, Trial manager (maternity cover) and a Biomarker data analyst. Find out more about the roles and how to apply below 🧪

Congratulations to Dr Maggie Cheang, Group Leader for Integrative Genomics Analysis in Clinical Trials, has been awarded the prestigious CL Oakley lectureship. 🧪

At #ESTRO2025, the 10-year results of the FAST-Forward #ClinicalTrial were presented. The results confirmed 5-year findings showing that treating early stage #BreastCancer with #Radiotherapy to the breast & chest wall over 1-week is as safe and effective as the standard 3-week treatment.

Our new #ClinicalTrial FAST-Forward Boost opened its first sites for recruitment in April, with a plan to open over 40 UK sites. The @nihr.bsky.social funded trial is being led by Dr Anna Kirby (Chief Investigator) and Professor Judith Bliss (Methodology Lead).

Last week, we attended the 22nd Annual Schools Science Conference at University of Westminster. Dr Holly Tovey, @hollytovey.bsky.social, one of our Principal Statisticians, enjoyed speaking to students about possible careers in #CancerResearch and #ClinicalTrials.